Vertex cystic fibrosis drug gets expanded approval for use in infants

[cafead]

via U.S. health regulators have expanded the use of one of Vertex Pharmaceuticals Inc’s cystic fibrosis drugs to include patients aged between 12 months and 24 months.

article source